Heping Kan
Overview
Explore the profile of Heping Kan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang Y, Xiao W, Liu R, Gao L, Chen J, Kan H
J Immunol Res
. 2022 Nov;
2022:4983532.
PMID: 36405011
Background: Lamin family members play crucial roles in promoting oncogenesis and cancer development. The values of lamin family in predicting prognosis and immunotherapy response remain largely unclarified. Our research is...
2.
Huang Y, Xiang B, Liu Y, Wang Y, Kan H
Cancer Lett
. 2022 Jul;
544:215825.
PMID: 35853767
No abstract available.
3.
Yang Y, Gao L, Chen J, Xiao W, Liu R, Kan H
Bioengineered
. 2022 Apr;
13(4):9211-9231.
PMID: 35436411
Hepatocellular carcinoma (HCC) is an aggressive malignancy. Previous studies have found that lamin B1 (LMNB1) contributes to the development of human cancers. However, the biological functions and prognostic values of...
4.
Chen J, Yang Y, Liu Y, Kan H
World J Surg Oncol
. 2021 Jan;
19(1):11.
PMID: 33436017
Objective: To investigate the prognostic factors of patients with pancreatic neuroendocrine tumor (pNETs) after surgical resection, and to analyze the value of enucleation for pNETs without distant metastasis that are...
5.
Liang Z, Li Y, Tian Y, Zhang H, Cai W, Chen A, et al.
Cancer Lett
. 2019 Apr;
452:268-269.
PMID: 30929810
No abstract available.
6.
Liang Z, Li Y, Tian Y, Zhang H, Cai W, Chen A, et al.
Cancer Lett
. 2019 Jan;
447:164-173.
PMID: 30677447
Tumor cells can escape immune surveillance through the programmed cell death protein 1 (PD-1) axis suppressing T cells. However, we recently demonstrated that high-affinity variants of soluble human programmed death-ligand...
7.
Huang Y, Xiang B, Liu Y, Wang Y, Kan H
Cancer Lett
. 2018 Aug;
437:56-66.
PMID: 30165194
Long non-coding RNAs (lncRNAs) show great potential as therapeutic targets in many diseases including hepatocellular carcinoma (HCC). Here, we aimed to investigate the clinical significance and function of lncRNA CDKN2B...
8.
Lin Y, Liu J, Huang Y, Liu D, Zhang G, Kan H
Transl Oncol
. 2017 Feb;
10(2):211-220.
PMID: 28189067
Dysregulation of microRNAs (miRNAs) is actively involved in the pathogenesis and tumorigenicity of hepatocellular carcinoma (HCC). miR-489 was found to play either oncogenic or tumor suppressive roles in human cancers....
9.
Kan H, Huang Y, Li X, Liu D, Chen J, Shu M
Oncotarget
. 2016 Feb;
7(12):14336-49.
PMID: 26893361
Zinc finger and BTB domain-containing 20 (ZBTB20) is a new BTB/POZ-domain gene and a member of the POK family of transcriptional repressors. Notably, the role of ZBTB20 and its underlying...
10.
Hu Z, Wang X, Guo W, Xie L, Huang Y, Liu Y, et al.
Oncotarget
. 2016 Feb;
7(10):11733-43.
PMID: 26887056
Our earlier findings indicate that the long non-coding RNA MALAT1 promotes colorectal cancer (CRC) cell proliferation, invasion and metastasis in vitro and in vivo by increasing expression of AKAP-9. In...